FOXP1 and neoplasm: Semi-quantitatively, we noticed that after the treatment with molecule 25, a decrease of FOXP1 immunoreactivity compared with the control was observed (p < 0.001, Figure 9D), pointing to a role of this molecule in controlling tumor cells’ migration via FOXP1.